Viewing Study NCT01107535


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-25 @ 7:50 PM
Study NCT ID: NCT01107535
Status: COMPLETED
Last Update Posted: 2012-10-31
First Post: 2010-02-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection
Sponsor: Abbott
Organization: